BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22197787)

  • 1. Comparative evaluation of Logan and relative-equilibrium graphical methods for parametric imaging of dynamic [18F]FDDNP PET determinations.
    Wong KP; Kepe V; Dahlbom M; Satyamurthy N; Small GW; Barrio JR; Huang SC
    Neuroimage; 2012 Mar; 60(1):241-51. PubMed ID: 22197787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tracer Kinetic Analysis of (S)-¹⁸F-THK5117 as a PET Tracer for Assessing Tau Pathology.
    Jonasson M; Wall A; Chiotis K; Saint-Aubert L; Wilking H; Sprycha M; Borg B; Thibblin A; Eriksson J; Sörensen J; Antoni G; Nordberg A; Lubberink M
    J Nucl Med; 2016 Apr; 57(4):574-81. PubMed ID: 26795290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Movement correction method for human brain PET images: application to quantitative analysis of dynamic 18F-FDDNP scans.
    Wardak M; Wong KP; Shao W; Dahlbom M; Kepe V; Satyamurthy N; Small GW; Barrio JR; Huang SC
    J Nucl Med; 2010 Feb; 51(2):210-8. PubMed ID: 20080894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-graphical analysis of dynamic PET.
    Zhou Y; Ye W; Brasić JR; Wong DF
    Neuroimage; 2010 Feb; 49(4):2947-57. PubMed ID: 19931403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative equilibrium plot improves graphical analysis and allows bias correction of standardized uptake value ratio in quantitative 11C-PiB PET studies.
    Zhou Y; Sojkova J; Resnick SM; Wong DF
    J Nucl Med; 2012 Apr; 53(4):622-8. PubMed ID: 22414634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using a reference tissue model with spatial constraint to quantify [11C]Pittsburgh compound B PET for early diagnosis of Alzheimer's disease.
    Zhou Y; Resnick SM; Ye W; Fan H; Holt DP; Klunk WE; Mathis CA; Dannals R; Wong DF
    Neuroimage; 2007 Jun; 36(2):298-312. PubMed ID: 17449282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatially constrained kinetic modeling with dual reference tissues improves
    Zhou Y; Flores S; Mansor S; Hornbeck RC; Tu Z; Perlmutter JS; Ances B; Morris JC; Gropler RJ; Benzinger TLS
    Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3172-3186. PubMed ID: 33599811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vivo Characterization and Quantification of Neurofibrillary Tau PET Radioligand
    Betthauser TJ; Cody KA; Zammit MD; Murali D; Converse AK; Barnhart TE; Stone CK; Rowley HA; Johnson SC; Christian BT
    J Nucl Med; 2019 Jan; 60(1):93-99. PubMed ID: 29777006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of [18F]FDDNP PET using subcortical white matter as reference region.
    Wong KP; Wardak M; Shao W; Dahlbom M; Kepe V; Liu J; Satyamurthy N; Small GW; Barrio JR; Huang SC
    Eur J Nucl Med Mol Imaging; 2010 Mar; 37(3):575-88. PubMed ID: 19882153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of pharmacokinetic modeling strategies for in-vivo quantification of tau with the radiotracer [
    Guehl NJ; Wooten DW; Yokell DL; Moon SH; Dhaynaut M; Katz S; Moody KA; Gharagouzloo C; Kas A; Johnson KA; El Fakhri G; Normandin MD
    Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2099-2111. PubMed ID: 31332496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic Evaluation of the Tau PET Radiotracer
    Wooten DW; Guehl NJ; Verwer EE; Shoup TM; Yokell DL; Zubcevik N; Vasdev N; Zafonte RD; Johnson KA; El Fakhri G; Normandin MD
    J Nucl Med; 2017 Mar; 58(3):484-491. PubMed ID: 27660144
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of Dosimetry, Quantitative Methods, and Test-Retest Variability of
    Bullich S; Barret O; Constantinescu C; Sandiego C; Mueller A; Berndt M; Papin C; Perrotin A; Koglin N; Kroth H; Pfeifer A; Tamagnan G; Madonia J; Seibyl JP; Marek K; De Santi S; Dinkelborg LM; Stephens AW
    J Nucl Med; 2020 Jun; 61(6):920-927. PubMed ID: 31712324
    [No Abstract]   [Full Text] [Related]  

  • 13. In Vivo Comparison of Tau Radioligands
    Betthauser TJ; Lao PJ; Murali D; Barnhart TE; Furumoto S; Okamura N; Stone CK; Johnson SC; Christian BT
    J Nucl Med; 2017 Jun; 58(6):996-1002. PubMed ID: 27856627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parametric Binding Images of the TSPO Ligand 18F-DPA-714.
    Golla SS; Boellaard R; Oikonen V; Hoffmann A; van Berckel BN; Windhorst AD; Virta J; Te Beek ET; Groeneveld GJ; Haaparanta-Solin M; Luoto P; Savisto N; Solin O; Valencia R; Thiele A; Eriksson J; Schuit RC; Lammertsma AA; Rinne JO
    J Nucl Med; 2016 Oct; 57(10):1543-1547. PubMed ID: 27261521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDDNP binding using MR derived cortical surface maps.
    Protas HD; Huang SC; Kepe V; Hayashi K; Klunder A; Braskie MN; Ercoli L; Bookheimer S; Thompson PM; Small GW; Barrio JR
    Neuroimage; 2010 Jan; 49(1):240-8. PubMed ID: 19703569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis.
    Lopresti BJ; Klunk WE; Mathis CA; Hoge JA; Ziolko SK; Lu X; Meltzer CC; Schimmel K; Tsopelas ND; DeKosky ST; Price JC
    J Nucl Med; 2005 Dec; 46(12):1959-72. PubMed ID: 16330558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simplified estimation of binding parameters based on image-derived reference tissue models for dopamine transporter bindings in non-human primates using [
    Odano I; Varrone A; Hosoya T; Sakaguchi K; Gulyás B; Padmanabhan P; Ghosh KK; Yang CT; Guenther I; Wang Z; Serrano R; Chimon NG; Halldin C
    Am J Nucl Med Mol Imaging; 2017; 7(6):246-254. PubMed ID: 29348979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limitations of small animal PET imaging with [18F]FDDNP and FDG for quantitative studies in a transgenic mouse model of Alzheimer's disease.
    Kuntner C; Kesner AL; Bauer M; Kremslehner R; Wanek T; Mandler M; Karch R; Stanek J; Wolf T; Müller M; Langer O
    Mol Imaging Biol; 2009; 11(4):236-40. PubMed ID: 19214638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parametric imaging of dual-time window [
    Heeman F; Yaqub M; Hendriks J; Bader I; Barkhof F; Gispert JD; van Berckel BNM; Lopes Alves I; Lammertsma AA
    Neuroimage; 2021 Jul; 234():117953. PubMed ID: 33762215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Test-retest reproducibility of cerebral adenosine A
    Toyohara J; Sakata M; Wagatsuma K; Tago T; Ishibashi K; Ishii K; Elsinga P; Ishiwata K
    Ann Nucl Med; 2022 Jan; 36(1):15-23. PubMed ID: 34564828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.